The meeting with Clinical Neurologist and Dermatologists in the Queen Sirikit National Institute of Child Health on 11/8/2009 was concluded that the following three activities shall be set up for the pharmacogenomics research collaboration between DMSc and the QSNICH. 1) Case-control study for association analysis of HLA-B*1502 in Thai Children who prescribed Carbamazepine. 2) Participating in the multi-center clinical research network for clinical investigation of SJS/TENS in Thailand. 3) Operational study for Prospective intervention using HLA-B*1502 status to prevent Carbamazepine induced SJS/TENS. |